Suche
Mein Konto
Bayer shares on the road to success: DZ BANK increases value to 36 euros!
DZ BANK increases the fair value of Bayer shares to 36 euros. Analyst Peter Spengler recommends “Buy” after positive quarterly figures.
Bayer shares on the road to success: DZ BANK increases value to 36 euros!
Analyst Peter Spengler from DZ BANK subjected Bayer shares to a thorough analysis and increased the fair value from 30 to 36 euros. This re-rating was published on May 13, 2025 and is part of positive coverage of the company, which has started 2025 better than expected. As a result, the price of Bayer shares in XETRA trading rose by 4.1 percent to 25.04 euros. A total of 8,478,914 shares have been traded so far, which indicates keen interest from investors.
The positive rating of the stock remains unchanged at “Buy”. This shows DZ BANK's confidence in the company's future development. Since the beginning of 2025, Bayer shares have gained a remarkable 30.3 percent in value, indicating the solid performance and optimistic prospects for the company. The publication date of the original study was at 2:46 p.m., while the initial distribution occurred a little later at 2:49 p.m.
Market development and price reaction
The striking increase in the price of Bayer shares shows that the market is reacting positively to the new valuation by DZ BANK. By increasing the fair value by six euros, investors trust that Bayer can continue to deliver solid results. This decision could also attract numerous long-term investors interested in long-term development.
The development of Bayer shares is in the context of a traditional company that has operated in a dynamic market in recent years. Experts and analysts are watching how the share will develop further, especially in view of the current changes in corporate strategy and market position.
For detailed information about possible conflicts of interest, DZ BANK refers to the disclosure requirement, which can be viewed at dpa-afx.de.
Overall, it can be said that the positive developments and the revaluation by DZ BANK put Bayer shares in a favorable light and investors can continue to look to the future with optimism.
Links to the sources: finance.net, boerse.de.